Cargando…
A promising iPS-based single-cell cloning strategy revealing signatures of somatic mutations in heterogeneous normal cells
Single-cell genomics has advanced rapidly as trace-DNA amplification technologies evolved. However, current technologies are subject to a variety of pitfalls such as contamination, uneven genomic coverage, and amplification errors. Even for the “golden” strategy of single stem cell-derived clonal fo...
Autores principales: | Miao, Xuexia, Li, Yueying, Zheng, Caihong, Wang, Lifei, Jin, Chen, Chen, Lei, Mi, Shuangli, Zhai, Weiwei, Wang, Qian-Fei, Cai, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493045/ https://www.ncbi.nlm.nih.gov/pubmed/32994891 http://dx.doi.org/10.1016/j.csbj.2020.08.026 |
Ejemplares similares
-
DSMNC: a database of somatic mutations in normal cells
por: Miao, Xuexia, et al.
Publicado: (2019) -
The Promise and Therapeutic Potential of Human ES and iPS Cells
por: Lu, Shi-Jiang, et al.
Publicado: (2011) -
Technological Overview of iPS Induction from Human Adult Somatic Cells
por: Bayart, Emilie, et al.
Publicado: (2013) -
Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014) -
Reprogramming resistant genes: in-depth comparison of gene expressions among iPS, ES, and somatic cells
por: Polouliakh, Natalia
Publicado: (2013)